Skip to main content
SHENZHEN LIFOTRONIC TECHNOLOGY CO.,LTD logo

SHENZHEN LIFOTRONIC TECHNOLOGY CO.,LTD — Investor Relations & Filings

Ticker · 688389 ISIN · CNE100005WZ5 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 812 across all filing types
Latest filing 2025-01-22 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 688389

About SHENZHEN LIFOTRONIC TECHNOLOGY CO.,LTD

https://en.lifotronic.com/

SHENZHEN LIFOTRONIC TECHNOLOGY CO.,LTD. specializes in the research, development, and manufacturing of medical equipment for therapeutic and diagnostic applications. The company’s therapeutic portfolio includes negative pressure wound therapy (NPWT) systems, high-frequency chest wall oscillation devices for airway clearance, and various physical therapy and rehabilitation solutions. In the field of in-vitro diagnostics, it offers high-performance liquid chromatography (HPLC) hemoglobin analyzers for diabetes management and chemiluminescence immunoassay (CLIA) platforms. Lifotronic integrates advanced engineering with clinical requirements to provide solutions for wound care, respiratory health, and laboratory testing. The company serves a global market, focusing on technological innovation and the delivery of precise, reliable medical instruments designed to improve patient outcomes across diverse clinical settings.

Recent filings

Filing Released Lang Actions
深圳普门科技股份有限公司监事会对注销2021年股票期权激励计划预留授予部分股票期权的核查意见
Board/Management Information Classification · 95% confidence The document is a supervisory board's verification opinion on the cancellation of reserved stock options under the company's 2021 stock option incentive plan. It references relevant laws and regulations and confirms the cancellation of unexercised stock options. The document is short (1172 characters) and focuses on a specific corporate governance action related to stock options, not a full financial report or earnings release. It is not an announcement of a report publication but a formal opinion from the supervisory board. This fits best under 'Board/Management Information' (MANG) as it relates to management-level decisions and disclosures about stock option plans and their cancellation.
2025-01-22 Chinese
北京市中伦（深圳）律师事务所关于深圳普门科技股份有限公司注销2021年股票期权激励计划预留授予部分股票期权相关事项的法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the cancellation of reserved stock options under a 2021 stock option incentive plan of Shenzhen Pumen Technology Co., Ltd. It discusses legal compliance, approvals by the board and shareholders, and the specifics of the stock option cancellation. The document is not a financial report, earnings release, or regulatory filing about financial results. It is a legal opinion related to stock option incentive plan matters, which does not fit into categories like Annual Report, Earnings Release, or Capital/Financing Update. It is also not a proxy solicitation or voting results announcement. The document is a standalone legal opinion letter, which is best classified under Regulatory Filings (RNS) as it does not fit other more specific categories and is a regulatory/legal compliance document.
2025-01-22 Chinese
深圳普门科技股份有限公司关于自愿披露控股子公司取得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the voluntary disclosure of its controlling subsidiaries obtaining medical device registration certificates. It details the registration certificates received, their validity, and the impact on the company. The document is short (986 characters) and serves as a regulatory announcement about product certification and market qualification, not a financial report or detailed management discussion. It does not contain financial data, earnings, or management changes. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-01-17 Chinese
深圳普门科技股份有限公司关于2021年、2022年、2023年股票期权激励计划2024年第四季度自主行权结果暨股份变动的公告
Transaction in Own Shares Classification · 95% confidence The document is a detailed announcement from Shenzhen Pumen Technology Co., Ltd. regarding the stock option incentive plans for the years 2021, 2022, and 2023, specifically focusing on the fourth quarter of 2024 autonomous exercise results and share changes. It includes extensive data on stock option grants, exercise periods, exercise quantities, board and supervisory meetings approving the plans, adjustments to exercise prices, cancellations of unexercised options, and shareholding changes due to option exercises. The document is lengthy (15,000 characters) and contains detailed substantive information about stock option exercises and resulting share capital changes, not merely an announcement or summary. It is not a general regulatory filing, nor a report publication announcement. It is not an earnings release or annual report. The content is focused on stock option exercises and resulting share capital changes, which aligns with the category of Transaction in Own Shares (POS), as it reports on the company's stock option exercises and resulting share issuance and shareholding changes. Therefore, the most appropriate classification is POS (Transaction in Own Shares).
2025-01-02 Chinese
深圳普门科技股份有限公司关于自愿披露控股子公司取得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (775 characters) from Shenzhen Pumen Technology Co., Ltd. regarding the voluntary disclosure of its controlling subsidiary obtaining a medical device registration certificate issued by the Guangdong Provincial Drug Administration. It describes the certificate details, product information, potential impact on the company, and risk warnings. There is no financial data, no mention of financial results, no regulatory certifications, or meeting materials. The document is an official announcement about a regulatory approval related to product registration, not a financial report or management change. It fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2024-12-20 Chinese
深圳普门科技股份有限公司关于自愿披露公司获得海关AEO高级认证企业证书的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the voluntary disclosure of receiving the AEO (Authorized Economic Operator) advanced certification from Shenzhen Customs. It describes the certification, its benefits, and the impact on the company's international business operations. There are no financial statements, no detailed financial data, no mention of annual or quarterly reports, no voting results, no management changes, no legal proceedings, or other regulatory filings. The document is an announcement of a certification achievement and its implications, not a financial report or regulatory filing. Given the content and length (958 characters), it fits best as a Regulatory Filing (RNS) since it is a general regulatory announcement that does not fit other specific categories.
2024-12-16 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.